Showing results (1881-1890 of 1,907) with videos related to
Sort By:
Pageof 191
Nature Materials|March 9, 2023
Single-crystalline van der Waals layered dielectric with high dielectric constantCongcong Zhang, Teng Tu, Jingyue Wang, et al.Acta Cardiologica Sinica|May 31, 2018
2018 Expert Consensus on the Management of Adverse Effects of Antiplatelet Therapy for Acute Coronary Syndrome in TaiwanYi-Heng Li, Chih-Yuan Fang, I-Chang Hsieh, et al.Cancer Medicine|July 2, 2020
Phase II trial of co-administration of CD19- and CD20-targeted chimeric antigen receptor T cells for relapsed and refractory diffuse large B cell lymphomaWei Sang, Ming Shi, Jingjing Yang, et al.Journal of the American Heart Association|July 9, 2024
Intensive Versus Moderate Statin-Based Therapies in Patients With Mild Ischemic Stroke: A Prospective Multicenter Cohort StudyHai-Mei Fan, Yong-le Wang, Kai-Li Zhang, et al.Haematologica|November 30, 2023
Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzumab in relapsed or refractory follicular lymphomaMatthew J Maurer, Carla Casulo, Melissa C Larson, et al.The Journal of Clinical Investigation|December 28, 2018
Long noncoding RNA NEXN-AS1 mitigates atherosclerosis by regulating the actin-binding protein NEXNYan-Wei Hu, Feng-Xia Guo, Yuan-Jun Xu, et al.Nature Communications|December 5, 2024
A penta-component mpox mRNA vaccine induces protective immunity in nonhuman primatesQing Ye, Dong Zhang, Rong-Rong Zhang, et al.The Lancet. Haematology|March 31, 2022
Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort studyCarla Casulo, Melissa C Larson, Julianne J Lunde, et al.Journal of Integrative Plant Biology|August 14, 2025
The miR172a-ERF416/413 module regulates soybean seed traitsMeng Jin, Jia-Qi Han, Lu-Yao Zhang, et al.Small Methods|October 27, 2022
An Engineered IgG-VHH Bispecific Antibody against SARS-CoV-2 and Its VariantsHang Chi, Lei Wang, Chanjuan Liu, et al.Pageof 191